View in EDS HTML Full Text PDF Full Text

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19.

Saved in:

Bibliographic Details
Title:	Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19.
Authors:	Hamilton, David Oliver^1,2 (AUTHOR), Main-Ian, Alexander¹ (AUTHOR), Tebbutt, Jessie¹ (AUTHOR), Thrasher, Maya¹ (AUTHOR), Waite, Alicia^1,2 (AUTHOR), Welters, Ingeborg^1,2 (AUTHOR) I.Welters@liverpool.ac.uk
Source:	Thrombosis Journal. 11/15/2021, Vol. 19 Issue 1, p1-5. 5p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	14779560
DOI:	10.1186/s12959-021-00337-z